Legal Representation
Attorney
Paul C. Llewellyn
USPTO Deadlines
Next Deadline
1008 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-04-26)
Due Date
April 26, 2028
Grace Period Ends
October 26, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 26, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 24, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Mar 23, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Mar 19, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 18, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 18, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 14, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 3, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 3, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 3, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 3, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 10, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 8, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 8, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 8, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 10, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 8, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 8, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 8, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 8, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 14, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 14, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 24, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 9, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 9, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 9, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 9, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 9, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 3, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 3, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 3, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 3, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 18, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Mar 17, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 14, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
medical and scientific research services, namely, medical research; medical and scientific research services all in the field of rare and infectious diseases; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies
First Use Anywhere:
Apr 4, 2020
First Use in Commerce:
Apr 4, 2020
Class 044
medical information services, namely, providing information relating to rare diseases, medicines, health conditions, and treatment options; Provision of health care services, namely, providing information to doctors and patients regarding rare diseases, medicines, health conditions and treatment options; providing a website featuring medical information in the field of rare and infectious diseases; providing a website featuring information in the field of the diagnosis and treatment of muscular dystrophies, neuromuscular diseases, and central nervous system diseases; providing a website featuring information in the field of medicine via electronic and optical communications networks
First Use Anywhere:
Apr 4, 2020
First Use in Commerce:
Apr 4, 2020
Additional Information
Design Mark
The mark consists of an abstract representation of the DNA double helix structure in white and gold. The color black shown in the mark is background and is not part of the mark.
Color Claim
The color(s) white and gold is/are claimed as a feature of the mark.
Classification
International Classes
042
044